» Articles » PMID: 20831794

The Proliferation, Apoptosis, Invasion of Endothelial-like Epithelial Ovarian Cancer Cells Induced by Hypoxia

Overview
Publisher Biomed Central
Specialty Oncology
Date 2010 Sep 14
PMID 20831794
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Epithelial ovarian cancer is one of the most malignant cancers in women because metastasis occurs in the most of patients by the time of diagnosis. Cancer cells have strong capacity to form angiogenesis or vasculogenic mimicry, which plays the major role in its malignant phenotype. Vasculogenic mimicry might contribute to the failure of the angiogenesis-targeted therapy strategies. Under the microenvironment of the tumor, hypoxia is the most common phenomena because of the vast energy and oxygen consuming. In the present study, the endothelial-like cells induced by hypoxia from SKOV-3 and ES-2 ovarian cancer cells were harvested to investigate the changes in their biological behaviors.

Methods: The endothelial-like cells from SKOV-3 and ES-2 cells were harvested by laser capture microdissection. The biological behaviors of the endothelial-like cells, including proliferation, cell cycle, apoptosis, invasion and telomerase activity were determined by MTT, FCM, Transwell chamber and TRAP-ELISA methods. HIF-1α is the most important factor for the behavior changes under hypoxic condition. Some other genes relative to biological behaviors are also changes following the changes of HIF-1α. In order to elucidate the underlying mechanisms for these changes by hypoxia, the relative genes expressions including HIF-1α, CyclinD1, Flk-1, VEGF, p53 and V-src were determined by real-time PCR.

Results: SKOV-3 and ES-2 cells were resistant to hypoxia by adoption of proliferation, apoptosis, differentiation and invasion. Combined with other studies, the more poorly cancer cells differentiate, the more strongly cells are resistant to hypoxia, the more possible to form vasculogenic mimicry. The changes in the expression of HIF-1α, and HIF-1α-dependent VEGF, Flk-1, Cyclin D1, and HIF-1α-independent p53 have been involved in this process.

Conclusions: HIF-1α took an important role in the behavioral changes of SKOV-3 and ES-2 cells by hypoxia. At the same time, other mechanisms were also involved in this process.

Citing Articles

Serum HIF-1α, IGF-1 and IGFBP-3 correlate to recurrence and overall survival in early-stage hepatocellular carcinoma patients.

Ding S, Ding W, Zhang Y, Chen Y, Tang H, Jiang X Biomark Med. 2024; 18(23):1027-1036.

PMID: 39552593 PMC: 11633424. DOI: 10.1080/17520363.2024.2421149.


Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma.

Liu Y, Xu X, Zhang Y, Mo Y, Sun X, Shu L Cell Death Dis. 2022; 13(6):536.

PMID: 35676251 PMC: 9177864. DOI: 10.1038/s41419-022-04959-7.


Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments.

Winter S, Miller H, Steinbach-Rankins J Pharmaceutics. 2021; 13(11).

PMID: 34834307 PMC: 8625169. DOI: 10.3390/pharmaceutics13111891.


Regulation of the Hypoxia-Inducible Factor (HIF) by Pro-Inflammatory Cytokines.

Malkov M, Lee C, Taylor C Cells. 2021; 10(9).

PMID: 34571989 PMC: 8466990. DOI: 10.3390/cells10092340.


IL-1β Promotes Vasculogenic Mimicry of Breast Cancer Cells Through p38/MAPK and PI3K/Akt Signaling Pathways.

Nisar M, Zheng Q, Saleem M, Ahmmed B, Ramzan M, Din S Front Oncol. 2021; 11:618839.

PMID: 34055597 PMC: 8160375. DOI: 10.3389/fonc.2021.618839.


References
1.
Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

2.
Millimaggi D, Mari M, D Ascenzo S, Giusti I, Pavan A, Dolo V . Vasculogenic mimicry of human ovarian cancer cells: role of CD147. Int J Oncol. 2009; 35(6):1423-8. DOI: 10.3892/ijo_00000460. View

3.
Lubin J, Markowska J, Markowska A, Stanislawiak J, Lukaszewski T . Activity of telomerase in ovarian cancer cells. Clinical implications. Clin Exp Obstet Gynecol. 2009; 36(2):91-6. View

4.
Rasila K, Burger R, Smith H, Lee F, Verschraegen C . Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer. 2005; 15(5):710-26. DOI: 10.1111/j.1525-1438.2005.00132.x. View

5.
Hopfl G, Wenger R, Ziegler U, Stallmach T, Gardelle O, Achermann R . Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res. 2002; 62(10):2962-70. View